Company Overview and News

5
Upcoming Tech Earnings to Watch: GOOGL, TXN, FB

1h zacks
Earnings season got busy this week with the remainder of the big financial firms, most of our top industrial companies, and the first wave of tech leaders announcing their latest quarterly results. This week saw solid results across the board, with impressive revenue growth punctuating continued EPS expansion.
FB TXN GOOGL

15
Did The DGI Newbie's 2014 Portfolio Fail Like High Yield Failed?

2h seekingalpha
Previous articles tracked how portfolios composed of high-yield CEFs, BDCs, MLPs and mREITs "failed" by underperforming the market significantly since 2014.
RSO.PRC HD HE GIS PG HE.PRU TXN RSO.PRBCL ADP RSO.PRACL MCQ RCL HRZN HTF BAX MCV OSLE VZA UHT IP CUKPF CCL HTFA INTC TUP RSO MCC WMC GD INPAP CCL CUK WM NMFC OCSL MCX ADPVV XAN PPL RTN ADI VZ RSO.PRA RSO.PRB

2
Texas Instruments (TXN) Analog & Embedded to Aid Q2 Earnings

6h zacks
Texas Instruments (TXN - Free Report) or TI is scheduled to report second-quarter 2018 results on Jul 24 after the bell.
SGMS TXN KDP CSX NVDA

4
The Zacks Analyst Blog Highlights: Wells Fargo, IBM, Abbott, Texas Instruments and Praxair

6h zacks
Chicago, IL –July 20, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Wells Fargo (WFC - Free Report) , IBM (IBM - Free Report) , Abbott (ABT - Free Report) , Texas Instruments (TXN - Free Report) and Praxair (PX - Free Report) .
WFCNP TXN MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG MS.PRA WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY MS WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS MS.PRI PX MS.PRK

34
My Dividend Growth Portfolio - Q2 2018 Summary

19h seekingalpha
I believe that someone who writes about financial assets should share his main holdings with his readers.
LMT FB GD GIS TXN XOM TWX UTX GOOG KMB K TWC GOOGL AAPL KHC SBUX ABBV MSFT ADM OHI MMP PFE ABBV

7
Top Stock Reports for Wells Fargo, IBM & Abbott

22h zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo (WFC), IBM (IBM) and Abbott (ABT). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
WFC WFCNP HD WFC.WS TXN WFC.PRL WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP PX WFC.PRO WFC.PRN CERN WFC.PRY WFC.PRX WFC.PRW WFC.PRV

19
Are CEOs Really Worth What They’re Paid?

2018-07-19 investorplace
Over the last few weeks Intel (NASDAQ:INTC), Papa John’s (NASDAQ:PZZA) and Texas Instruments (NYSE:TXN) have all gotten rid of their high-priced CEOs, but their stocks have barely budged.
NWL GS TXN T CMCSA CELG INTC PZZA

0
Has Texas Instruments (TXN) Outpaced Other Computer and Technology Stocks This Year?

2018-07-19 zacks
Investors focused on the Computer and Technology space have likely heard of Texas Instruments (TXN - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's year-to-date performance in comparison to the rest of the Computer and Technology sector should help us answer this question.
TXN

0
Is Texas Instruments (TXN) Outperforming Other Computer and Technology Stocks This Year?

2018-07-19 zacks
Investors focused on the Computer and Technology space have likely heard of Texas Instruments (TXN - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Computer and Technology peers, we might be able to answer that question.
TXN

7
Taiwan Semi (TSM) Q2 Earnings Top Estimates, Revenues In Line

2018-07-19 zacks
Taiwan Semiconductor Manufacturing Company (TSM - Free Report) delivered second-quarter 2018 earnings of 47 cents per ADR unit surpassing the Zacks Consensus Estimate by 2 cents and also improved the year-ago quarter figure of 42 cents. However, it declined from the previous quarter figure of 59 cents. Adjusted revenues grew 11.2% on a year-over-year basis but fell 7.2% sequentially to $7.85 billion.
TXN ADI AME

0
Texas Instruments CEO Resigns Over Personal Conduct Violations

2018-07-18 investorplace
According to a statement from the company, Texas Instruments CEO Brian Crutcher has resigned from his roles at the company after violating its code of conduct. The company doesn’t say exactly what happened, but it notes that the former CEO’s actions are not consistent with its ethics and core values.
TXN

0
US stocks flat on solid earnings, weak housing data

2018-07-18 malaymail
NEW YORK, July 18 — Wall Street stocks were little changed early today following lacklustre housing data and a batch of mostly good earnings reports.
TXN MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

0
Texas Instruments: Reasons To Buy On The News

2018-07-18 seekingalpha
The good news is that the chairman, the prior longstanding CEO, has returned, and not just temporarily.
TXN

16
Texas Instruments' CEO Resigns on Code of Conduct Violation

2018-07-18 zacks
Texas Instruments, Inc. (TXN - Free Report) recently announced that Brian Crutcher has resigned as the company’s chief executive officer (CEO).
GRPN GEC GE TXN CTRP GNE

0
TXN / Texas Instruments Inc. 8-K (Current Report)

2018-07-18 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
TXN

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to TXN / Texas Instruments Inc. on message board site Silicon Investor.

Texas Instruments - Good buy now or should we wait? Stratex Networks, Inc. (STXN)
STXN: DMC Stratex Networks Inc. NOK EDMC TXN ALTR MU
Possible Hot Tech Plays (TXN, QWST, AMCC, etc...) A Discussion re. Memory: MU CY TXN ALSC IDTI ISSI etc.
Texas Instruments (TXN) INTC, TXN, AMD or CRUS - WHAT should I buy?
CUSIP: 882508104